Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 11Phase 2/3 4Phase 1/2 4Phase 4 3Phase 1 3Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Drug-Related Side Effects and Adverse Reactions 2Colorectal Neoplasms 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Quality of Life 1Peritoneal Metastases From Gastric Cancer 1Ovarian Cancer Recurrent 1Osteosarcoma 1Meningioma 1Immune Checkpoint Inhibition 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Adenocarcinoma 1

Interventions

Oxaliplatin 10Endoscopic Mucosal Resection 10Surgical Procedures, Operative 8Standard of Care 8Exercise 7Laparoscopy 6Fluorouracil 6Drug Therapy 6Sodium Chloride 5Leucovorin 5Gastroenterostomy 5Gastrectomy 5Endoscopy, Digestive System 5Saline Solution 4S 1 (combination) 4Preoperative Exercise 4Practice Guidelines as Topic 4Dietary Supplements 4Control Groups 4Biopsy 4Acupuncture Therapy 4Surveys and Questionnaires 3Ropivacaine 3Paclitaxel 3Nutrition Assessment 3Narrow Band Imaging 3Methods 3Indocyanine Green 3Hyperthermic Intraperitoneal Chemotherapy 3Hematologic Tests 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Stomach Neoplasms × apatinib × Clear all
NCT02764268 2022-03-11

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase NA Completed
60 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡